サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1676271

レジオネラ菌検査の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）

Global Legionella Testing Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 142 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
レジオネラ菌検査の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 142 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レジオネラ菌検査の世界市場規模は、2024年の3億2,242万米ドルから2033年までには6億5,975万米ドルに成長し、2026年から2033年の予測期間中に0.083％の堅調な年間平均成長率（CAGR）を示すと予測されます。

レジオネラ菌検査市場は、レジオネラ菌に関連する健康リスクに対する意識の高まりと、効果的な検査ソリューションに対する需要の高まりによって、大きな成長を遂げようとしています。レジオネラ症の発生が公衆衛生の脅威となり続ける中、ヘルスケア施設、水管理会社、規制機関は、レジオネラ汚染を検出し制御するための強固な検査プロトコルの導入を優先しています。この市場には、培養ベースの技術、ポリメラーゼ連鎖反応（PCR）アッセイ、迅速検査キットなど、さまざまな検査法があり、技術の進歩によって検査結果の精度とスピードが向上しています。

さらに、水質管理と安全規制の重視の高まりが、レジオネラ菌検査市場に影響を与えています。政府や保健機関がヘルスケア施設、ホテル、公共施設の水システムに対してより厳しいガイドラインを設ける中、信頼性の高い検査ソリューションに対する需要が急増しています。この動向は、規制基準に準拠し、水管理のための実用的な知見を提供する革新的な検査製品の開発をメーカーに促しています。

さらに、公衆衛生における予防対策とリスク評価への関心の高まりが、レジオネラ菌検査市場の技術革新を促進しています。検査機関、環境機関、ヘルスケアプロバイダー間の協力が検査手法と技術の進歩を促進し、新製品がさまざまな分野の進化するニーズに確実に応えています。アウトブレイクを予防するための積極的なレジオネラ菌管理の重要性に対する認識の高まりも、市場の成長に寄与しています。まとめると、レジオネラ菌検査市場は、技術の進歩、規制遵守への注力、公衆衛生の安全性向上へのコミットメントを特徴とし、力強い成長を遂げると考えられています。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察をお客様に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主な促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳します。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場プレイヤーの包括的評価をします。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 レジオネラ菌検査産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル開発動向

第5章 レジオネラ菌検査の世界市場分析：検査タイプ別

  • 概要：検査タイプ別
  • 過去と予測データ分析：検査タイプ別
  • 培養培地
  • 尿中抗原検査
  • ポリメラーゼ連鎖反応
  • 血清検査
  • 直接蛍光抗体法

第6章 レジオネラ菌検査の世界市場分析：用途別

  • 概要：用途別
  • 過去と予測データ分析：用途別
  • 水質検査
  • IVD検査

第7章 レジオネラ菌検査の世界市場分析：最終用途別

  • 概要：最終用途別
  • 過去と予測データ分析：最終用途別
  • 病院
  • 診療所
  • 診断ラボ
  • 水処理産業

第8章 レジオネラ菌検査の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第9章 レジオネラ菌検査企業の競合情勢

  • レジオネラ菌検査市場の競合
  • 提携/協力/合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.
  • BioMéRieux SA
  • Becton
  • Dickinson And Company
  • Qiagen N.V.
  • Bio-Rad Laboratories Inc.
  • Merck KGaA
  • IDEXX Laboratories Inc.
  • Abbott Laboratories
  • Roche Diagnostics
  • Pro-Lab Diagnostics Inc.
  • Eiken Chemical Co. Ltd.
  • Hologic Inc.
  • Takara Bio Inc.
  • Phigenics LLC
  • Aquacert Ltd
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Test Type (USD MN)
  • Culture Media Market Sales By Geography (USD MN)
  • Urine Antigen Testing Market Sales By Geography (USD MN)
  • Polymerase Chain Reaction Market Sales By Geography (USD MN)
  • Serology Market Sales By Geography (USD MN)
  • Direct Fluorescent Antibody Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Water Testing Market Sales By Geography (USD MN)
  • IVD Testing Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Diagnostic Labs Market Sales By Geography (USD MN)
  • Water Treatment Industries Market Sales By Geography (USD MN)
  • Global Legionella Testing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Legionella Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global Legionella Testing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Test Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Test Type (USD MN)
  • Culture Media Market Sales By Geography (USD MN)
  • Urine Antigen Testing Market Sales By Geography (USD MN)
  • Polymerase Chain Reaction Market Sales By Geography (USD MN)
  • Serology Market Sales By Geography (USD MN)
  • Direct Fluorescent Antibody Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Water Testing Market Sales By Geography (USD MN)
  • IVD Testing Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Diagnostic Labs Market Sales By Geography (USD MN)
  • Water Treatment Industries Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11212751

Global Legionella Testing Market size is anticipated to grow from USD 322.42 Million in 2024 to USD 659.75 Million by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 0.083% during the forecast period of 2026 to 2033.

The legionella testing market is poised for significant growth, driven by the increasing awareness of the health risks associated with Legionella bacteria and the rising demand for effective testing solutions. As outbreaks of Legionnaires' disease continue to pose a public health threat, healthcare facilities, water management companies, and regulatory bodies are prioritizing the implementation of robust testing protocols to detect and control Legionella contamination. The market encompasses a range of testing methods, including culture-based techniques, polymerase chain reaction (PCR) assays, and rapid testing kits, with advancements in technology enhancing the accuracy and speed of results.

Moreover, the growing emphasis on water quality management and safety regulations is influencing the legionella testing market. As governments and health organizations establish stricter guidelines for water systems in healthcare facilities, hotels, and public buildings, the demand for reliable testing solutions is surging. This trend is prompting manufacturers to develop innovative testing products that comply with regulatory standards and provide actionable insights for water management.

Furthermore, the increasing focus on preventive measures and risk assessment in public health is fostering innovation in the legionella testing market. Collaborations between testing laboratories, environmental agencies, and healthcare providers are driving advancements in testing methodologies and technologies, ensuring that new products meet the evolving needs of various sectors. The growing awareness of the importance of proactive legionella management in preventing outbreaks is also contributing to market growth. In summary, the legionella testing market is set for robust growth, characterized by technological advancements, a focus on regulatory compliance, and a commitment to enhancing public health safety.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Test Type

  • Culture Media
  • Urine Antigen Testing
  • Polymerase Chain Reaction
  • Serology
  • Direct Fluorescent Antibody

By Application

  • Water Testing
  • IVD Testing

By End-Use

  • Hospitals
  • Clinics
  • Diagnostic Labs
  • Water Treatment Industries
  • COMPANIES PROFILED
  • Pro-lab Diagnostics Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Alere Inc.
  • Roche Diagnostics
  • Eiken Chemical Co. Ltd.
  • Hologic Inc.
  • QIAGEN
  • Takara Bio Inc.
  • Environmental Safety Technologies Inc.
  • Phigenics
  • Hydrosense
  • Accepta Ltd.
  • LuminUltra Technologies Ltd.
  • Pro-Lab Diagnostics Inc.
  • BioAlert Solutions
  • Pacific Water Technology
  • Aquacert Ltd.
  • DTK Water
  • Sens Solutions
  • Genomadix Inc.
  • Phigenics LLC.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. LEGIONELLA TESTING INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Test Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-Use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL LEGIONELLA TESTING MARKET ANALYSIS BY TEST TYPE

  • 5.1. Overview By Test Type
  • 5.2. Historical and Forecast Data Analysis By Test Type
  • 5.3. Culture Media Historic and Forecast Sales By Regions
  • 5.4. Urine Antigen Testing Historic and Forecast Sales By Regions
  • 5.5. Polymerase Chain Reaction Historic and Forecast Sales By Regions
  • 5.6. Serology Historic and Forecast Sales By Regions
  • 5.7. Direct Fluorescent Antibody Historic and Forecast Sales By Regions

6. GLOBAL LEGIONELLA TESTING MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Water Testing Historic and Forecast Sales By Regions
  • 6.4. IVD Testing Historic and Forecast Sales By Regions

7. GLOBAL LEGIONELLA TESTING MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-Use
  • 7.2. Historical and Forecast Data Analysis By End-Use
  • 7.3. Hospitals Historic and Forecast Sales By Regions
  • 7.4. Clinics Historic and Forecast Sales By Regions
  • 7.5. Diagnostic Labs Historic and Forecast Sales By Regions
  • 7.6. Water Treatment Industries Historic and Forecast Sales By Regions

8. GLOBAL LEGIONELLA TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE LEGIONELLA TESTING COMPANIES

  • 9.1. Legionella Testing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF LEGIONELLA TESTING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Thermo Fisher Scientific Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. BioMéRieux SA
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Becton
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Dickinson And Company
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Qiagen N.V.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Bio-Rad Laboratories Inc.
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Merck KGaA
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. IDEXX Laboratories Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Abbott Laboratories
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Roche Diagnostics
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Pro-Lab Diagnostics Inc.
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Eiken Chemical Co. Ltd.
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Hologic Inc.
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. Takara Bio Inc.
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17. Phigenics LLC
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments
  • 10.18. Aquacert Ltd
    • 10.18.1 Company Overview
    • 10.18.2 Company Revenue
    • 10.18.3 Products
    • 10.18.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies